TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts.
about
Enabling functional genomics with genome engineeringStrategies for precision modulation of gene expression by epigenome editing: an overviewThe epigenome: the next substrate for engineeringCRISPR-Mediated Epigenome EditingEpigenetic Editing: On the Verge of Reprogramming Gene Expression at WillTargeted DNA methylation in pericentromeres with genome editing-based artificial DNA methyltransferase.Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein.Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation.TALEored Epigenetics: A DNA-Binding Scaffold for Programmable Epigenome Editing and Analysis.P16-specific DNA methylation by engineered zinc finger methyltransferase inactivates gene transcription and promotes cancer metastasis.MethylAction: detecting differentially methylated regions that distinguish biological subtypes.Editing the epigenome: technologies for programmable transcription and epigenetic modulation.Repurposing the CRISPR-Cas9 system for targeted DNA methylation.Advanced Gene Manipulation Methods for Stem Cell Theranostics.Controlling transcription in human pluripotent stem cells using CRISPR-effectors.Neuropathology of suicide: recent findings and future directions.Editing DNA Methylation in the Mammalian Genome.Drugging the methylome: DNA methylation and memory.Transient Tcf3 Gene Repression by TALE-Transcription Factor Targeting.Next stop for the CRISPR revolution: RNA-guided epigenetic regulators.Insight from animal models of environmentally driven epigenetic changes in the developing and adult brain.Rewriting DNA Methylation Signatures at Will: The Curable Genome Within Reach?From profiles to function in epigenomics.Epigenetic control of β-cell function and failure.Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.Modern Genome Editing Technologies in Huntington's Disease Research.DNA methylation profiling in human lung tissue identifies genes associated with COPD.Epigenetics in formation, function, and failure of the endocrine pancreas.Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3L methyltransferase.Epigenetic Editing of Ascl1 Gene in Neural Stem Cells by Optogenetics.Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors.Cancer induction and suppression with transcriptional control and epigenome editing technologies.Harnessing natural DNA modifying activities for editing of the genome and epigenome.Epigenetic Analysis of Endocrine Cell Subtypes from Human Pancreatic Islets.Engineering of the epigenome: synthetic biology to define functional causality and develop innovative therapies.Using induced pluripotent stem cells to explore genetic and epigenetic variation associated with Alzheimer's disease.Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.MICMIC: identification of DNA methylation of distal regulatory regions with causal effects on tumorigenesis.Epigenomics and human adaptation to high altitude
P2860
Q26782747-078CFACF-0C3E-40C5-ACD0-E34BFBA42DB2Q26782876-ACF43220-7CE8-4930-B25F-BC89FA1D9A37Q28068278-E3146148-1C7A-4C1E-9EEF-E8CA90FD2B91Q28075872-C5DA237F-3700-4B17-9759-BA7E47C123AEQ28080188-1608FAA9-7DB3-4E84-BAA5-02E9567A4E0CQ33703762-6C1DD986-9F50-4BD0-A3F4-8233DDB9E8A1Q33900031-FA22EE7C-5B30-4397-A7E0-80CC6777B705Q34526213-D81FCFDA-3507-40BE-A8A9-B79A51E1995FQ35955504-5E454E7C-7331-4DDD-B13D-90C7C9AFE820Q36307848-43EF72A1-41E9-463F-8DC6-174017A1966BQ36443334-0FD8889C-E4ED-45DB-9392-87246B106466Q37042113-95BCF9AA-21E4-47BB-8869-345D86DC2E8FQ37076267-905488EE-40CA-48D3-B16A-6B6D4631FF7BQ38287471-65BA00CC-C756-432C-9A6E-469A379CAEFEQ38622601-0C91559D-37F4-4500-B1B5-B6511F6262EDQ38659366-13022DEC-6E1D-4E22-A662-EB0EE832BED4Q38744151-172B7345-8FE2-409D-A49B-262616AC4C7DQ38750126-33C8730A-6BED-4076-9D8C-3D954F24E452Q38758515-6135F384-399C-47A4-A386-61CFE901F4A1Q38850026-91528968-C4CA-46B2-8BA3-537E44554256Q38968515-BD147B55-8646-4AAD-8EE7-64EFD286A763Q39003561-363B952D-0ACD-444E-B603-E56CBAB5436AQ39014872-593086CF-CA7B-4888-A54D-0410FD906907Q39029575-2110B6AC-7012-4285-88EC-E0D3235D7F18Q39036473-22D71EF7-9A3D-4DB8-9F6F-8F7779260B6DQ39106522-8F3A48AB-ED42-497A-8F33-10C0FAC81834Q41665058-A6DCA459-EC66-456E-ADEF-77A40B76C2A0Q41689688-932B9E06-51CD-4726-B70A-AF13FAC52836Q42291815-1147E028-8DA1-48BD-8F76-7A64721B2899Q42322827-242BD8A9-EEFB-444E-93A5-F33CAECE3400Q44573227-367B4CC0-9732-4C23-A086-8488DDFA6737Q47585554-5C1D221E-544C-4714-92D3-8729E2C1B4F5Q49917892-60214411-A763-4F7A-A2BD-F5F1A480DBE7Q51069692-739C7904-F894-4ADF-8C3A-C04CE1F3B1F4Q51553005-95D68780-6795-4FDA-93EF-F2FC124C1DFDQ51779584-E458939B-EBA3-412E-9001-99FCA4D9184BQ52360880-BEBCD093-5076-4883-8FB9-8D549C725366Q52431433-BF91D477-8144-45CA-B93C-99B7CF0633F1Q55236735-4024F324-ACCD-4DF8-B034-3CFCE0F23E27Q57093366-9F496473-6A6B-409D-8C98-24EFC09E83B2
P2860
TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
TALE-mediated epigenetic suppr ...... lication in human fibroblasts.
@ast
TALE-mediated epigenetic suppr ...... lication in human fibroblasts.
@en
type
label
TALE-mediated epigenetic suppr ...... lication in human fibroblasts.
@ast
TALE-mediated epigenetic suppr ...... lication in human fibroblasts.
@en
prefLabel
TALE-mediated epigenetic suppr ...... lication in human fibroblasts.
@ast
TALE-mediated epigenetic suppr ...... lication in human fibroblasts.
@en
P2093
P2860
P356
P1476
TALE-mediated epigenetic suppr ...... lication in human fibroblasts.
@en
P2093
Diana L Bernstein
Elena G Ruano
John E Le Lay
Klaus H Kaestner
P2860
P304
P356
10.1172/JCI77321
P407
P577
2015-04-13T00:00:00Z